Description
ACE-031 is a recombinant fusion protein — an engineered construct combining the extracellular domain of the activin receptor IIB with an antibody Fc fragment — designed to bind and neutralise myostatin and related TGF-β superfamily ligands. That receptor-decoy mechanism is what separates ACE-031 from the myostatin-binding approach used by Follistatin elsewhere in this catalogue, since ACE-031 works by mimicking the receptor rather than sequestering the ligand through a natural binding protein.
Researchers studying myostatin-pathway inhibition frequently compare ACE-031 against Follistatin to characterise how different neutralisation strategies (receptor-decoy versus natural binding protein) affect downstream muscle-signalling research outcomes.
After you place your order, a licensed physician will speak with you directly on a live call to review your health history and confirm a prescription is medically appropriate before anything ships. If your order isn’t approved, our team will contact you directly instead of shipping it. Reconstitute with bacteriostatic water and store refrigerated, protected from light.
